KPC Pharmaceuticals,Inc.

SHSE:600422 Rapport sur les actions

Capitalisation boursière : CN¥11.5b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

KPC PharmaceuticalsInc Croissance future

Future contrôle des critères 3/6

KPC PharmaceuticalsInc is forecast to grow earnings and revenue by 27.1% and 13.3% per annum respectively. EPS is expected to grow by 26.8% per annum. Return on equity is forecast to be 12.3% in 3 years.

Informations clés

27.1%

Taux de croissance des bénéfices

26.8%

Taux de croissance du BPA

Pharmaceuticals croissance des bénéfices18.8%
Taux de croissance des recettes13.3%
Rendement futur des capitaux propres12.3%
Couverture par les analystes

Good

Dernière mise à jour13 Aug 2024

Mises à jour récentes de la croissance future

Recent updates

KPC PharmaceuticalsInc (SHSE:600422) Will Pay A Larger Dividend Than Last Year At CN¥0.20

Jul 25
KPC PharmaceuticalsInc (SHSE:600422) Will Pay A Larger Dividend Than Last Year At CN¥0.20

Investors Still Waiting For A Pull Back In KPC Pharmaceuticals,Inc (SHSE:600422)

Jun 25
Investors Still Waiting For A Pull Back In KPC Pharmaceuticals,Inc (SHSE:600422)

We Think KPC PharmaceuticalsInc (SHSE:600422) Can Stay On Top Of Its Debt

Jun 04
We Think KPC PharmaceuticalsInc (SHSE:600422) Can Stay On Top Of Its Debt

KPC PharmaceuticalsInc's (SHSE:600422) Profits May Not Reveal Underlying Issues

Mar 28
KPC PharmaceuticalsInc's (SHSE:600422) Profits May Not Reveal Underlying Issues

Prévisions de croissance des bénéfices et des revenus

SHSE:600422 - Estimations futures des analystes et données financières antérieures (CNY Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/202611,0089491681,0216
12/31/20259,9247792797907
12/31/20248,563597-337206
3/31/20247,646432752811N/A
12/31/20237,703445291356N/A
9/30/20237,700397261333N/A
6/30/20237,825390141222N/A
3/31/20237,828400-5138N/A
12/31/20228,282383152254N/A
9/30/20228,419446177296N/A
6/30/20228,388392-23143N/A
3/31/20228,722427-33177N/A
12/31/20218,25450815252N/A
9/30/20218,321540-13693N/A
6/30/20218,386564-22190N/A
3/31/20218,045560-79118N/A
1/1/20217,717457251410N/A
9/30/20207,779445128361N/A
6/30/20207,788444104393N/A
3/31/20207,910443292564N/A
12/31/20198,12045482430N/A
9/30/20197,817429145452N/A
6/30/20197,473390131376N/A
3/31/20197,237356146402N/A
12/31/20187,102336135352N/A
9/30/20186,797316362568N/A
6/30/20186,507295162396N/A
3/31/20186,280318-69197N/A
12/31/20175,852330N/A283N/A
9/30/20175,637357N/A-5N/A
6/30/20175,330374N/A165N/A
3/31/20175,170416N/A179N/A
12/31/20165,101407N/A311N/A
9/30/20165,161440N/A326N/A
6/30/20165,227448N/A378N/A
3/31/20165,049433N/A491N/A
12/31/20154,916421N/A477N/A
9/30/20154,588404N/A485N/A
6/30/20154,456367N/A391N/A
3/31/20154,361308N/A447N/A
12/31/20144,316289N/A404N/A
9/30/20144,038264N/A338N/A
6/30/20143,860258N/A467N/A
3/31/20143,668243N/A325N/A
12/31/20133,584232N/A242N/A
9/30/20133,337223N/A210N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: 600422's forecast earnings growth (27.1% per year) is above the savings rate (2.9%).

Bénéfices vs marché: 600422's earnings (27.1% per year) are forecast to grow faster than the CN market (21.9% per year).

Croissance élevée des bénéfices: 600422's earnings are expected to grow significantly over the next 3 years.

Chiffre d'affaires vs marché: 600422's revenue (13.3% per year) is forecast to grow slower than the CN market (13.4% per year).

Croissance élevée des revenus: 600422's revenue (13.3% per year) is forecast to grow slower than 20% per year.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: 600422's Return on Equity is forecast to be low in 3 years time (12.3%).

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y